CRISPR Therapeutics CRSP Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Property, Plant, and Equipment at other companies
Other financials
Where this comes from
Reported directly by CRISPR Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The official record: CRISPR Therapeutics’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about CRISPR Therapeutics's payments to acquire property, plant, and equipment.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CRISPR Therapeutics's payments to acquire property, plant, and equipment?
- CRISPR Therapeutics (CRSP) reported payments to acquire property, plant, and equipment of $504K in Q1 2026.
- How has CRISPR Therapeutics's payments to acquire property, plant, and equipment changed year-over-year?
- CRISPR Therapeutics's payments to acquire property, plant, and equipment increased by 144.7% year-over-year, from $206K to $504K.
- What is the long-term trend for CRISPR Therapeutics's payments to acquire property, plant, and equipment?
- Over 4 years (2021 to 2025), CRISPR Therapeutics's payments to acquire property, plant, and equipment has grown at a -67.5% compound annual growth rate (CAGR), from $81.71M to $914K.